Don’t Sweat the Triple Threat: Breakthrough Therapy for Cystic Fibrosis

Rochester, NY US
October 21, 2020

This activity will serve dual purposes. Cystic fibrosis was previously considered a pediatric disease given patient’s low life expectancy. However, with increasing life expectancy of these patients, it is crucial that both adult and pediatric pharmacists are familiar with this disease and current treatment modalities. This presentation will address the knowledge gap present for the adult pharmacists attending the activity. Moreover, this presentation will provide pharmacists the opportunity to learn about the CFTR modulators currently being used for patients with CF, including the most newly approved breakthrough therapy, elexacaftor/tezacaftor/ivacaftor.

Target Audience

  • Pharmacists

Learning Objectives

  1. Review the pathophysiology, clinical manifestations, and current treatment modalities for cystic fibrosis (CF)
  2. Discuss the role of cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the long term management of CF
  3. Evaluate current literature surrounding the use of elexacaftor/tezacaftor/vacaftor for patients with CF
  4. Compare FDA approved CFTR modulators and recognize key differences between agents

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance
Course opens: 
10/21/2020
Course expires: 
12/06/2020
Event starts: 
10/21/2020 - 7:00am
Event ends: 
10/21/2020 - 8:00am
Cost:
$0.00
University of Rochester Medical Center
601 Elmwood Ave.
Rochester, NY 14642
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
 
Planning committee members
Linda Thomas, PharmD, BCPS
Pharmacy Residency Coordinator
University of Rochester Medical Center
 
David Hutchinson, PharmD, BCPS, BCPPS
Associate Professor of Pharmacy Practice
Wegmans School of Pharmacy at St. John Fisher College
 
Course reviewer
Gretchen Brummel, PharmD, BCPS
Consulting Director, Pharmacy
Vizient
 
Presenter
Sarah Bisesi, PharmD
PGY2 Pediatric Pharmacy Resident
University of Rochester Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and University of Rochester Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-190-L01-P
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.